Priority Date: 13.08.10 (EP 20100172841)

ANTI-TENASCIN-C A2 ANTIBODIES AND METHODS OF USE

  • Application ID: EP11743523
  • Status: GRANT OF PATENT INTENDED

Applicant

Technology company logo small
Technology Company

Attorney

no operation time available
1 office
Technology Company

Specialization

This EP application has the IPC combination A61, C07, and G01. We found, that TransMIT GmbH, Kailuweit & Uhlemann, dompatent von Kreisler Selting Werner - Partnerschaft von Patent- und Rechtsanwälten mbB, Avidity IP Ltd, Mewburn Ellis LLP and 55 others are specialized in this combination either. For a similar patent, they might be a good choice.

Timeline

  • 13.08.2010 - Priority Date (EP 20100172841)
  • 16.02.2012 - Publication A1 (WO2012020038)
  • 19.06.2013 - Publication A1 (EP2603529)

IPC Classification